Qube Research & Technologies LTD Simulations Plus, Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 14,275 shares of SLP stock, worth $470,218. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,275Holding current value
$470,218% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding SLP
# of Institutions
172Shares Held
15.2MCall Options Held
5.4KPut Options Held
1.4K-
Black Rock Inc. New York, NY2.46MShares$81.2 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC1.94MShares$63.8 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$37.9 Million0.0% of portfolio
-
Ranger Investment Management, L.P. Dallas, TX902KShares$29.7 Million1.9% of portfolio
-
State Street Corp Boston, MA640KShares$21.1 Million0.0% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $669M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...